Skip to search formSkip to main contentSkip to account menu

Suradista

A sulfonated distamycin A derivative exhibiting antiangiogenic activity. Suradista binds to the heparin and the selenate-binding sites on basic… 
National Institutes of Health

Related topics

Related topics

2 relations
FCE 26644

Narrower (1)

PNU 145156E

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Leads for Development of New Naphthalenesulfonate Derivatives with Enhanced Antiangiogenic Activity
Inhibition of angiogenesis-promoting factors such as fibroblast growth factors is considered to be a potential procedure for… 
2002
2002
Suradista NSC 651016 inhibits the angiogenic activity of CXCL12-stromal cell-derived factor 1alpha.
CXCL12 (stromal cell-derived factor 1alpha), a ligand for CXCR4, has been shown to induce endothelial cell chemotaxis and to… 
2002
2002
Suradista NSC 651016 Inhibits the Angiogenic Activity of CXCL12-Stromal Cell-derived Factor 1 (cid:1) 1
CXCL12 (stromal cell-derived factor 1 (cid:1) ), a ligand for CXCR4, has been shown to induce endothelial cell chemotaxis and to… 
2000
2000
Research on anti-HIV-1 agents. Investigation on the CD4-Suradista binding mode through docking experiments
Sulfonated distamycin (Suradista) derivatives exhibit anti-HIV-1 activity by inhibiting the binding of the viral envelope… 
1997
1997
Inhibition of growth factor mitogenicity and growth of tumor cell xenografts by a sulfonated distamycin A derivative.
Interference with growth factor-receptor interactions may have particular relevance in efforts to intervene clinically in both… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)